Published February 2022

This evidence in focus systematically reviews available clinical trial data detailing aducanumab use in individuals with early symptomatic Alzheimer disease and presents clinical considerations regarding use.

Published February 2008

In this practice parameter, we attempt to answer these questions: Which neurologic conditions are associated with an increased risk of falling? Are there practical clinical screening methods for neurologists that can accurately identify older patients and those with chronic neurologic conditions who

Published April 2010

This parameter is an update of the 2000 American Academy of Neurology (AAN) practice parameter on driving and dementia. In addition, this parameter seeks to identify historical features that are associated with increased driving risk. Reaffirmed on January 22, 2022.

Published May 2001

The AAN previously published a practice parameter on dementia in 1994. New research and clinical developments warrant an update of some aspects of diagnosis. Guideline being updated. Last reaffirmed on February 14, 2004.